Screener
SELLAS Life Sciences Group, Inc. SLS Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001390478-26-000008
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total assets | $114,177 | $78,345 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $3,633 | $2,948 |
| Accrued expenses and other current liabilities | 2,261 | 3,525 |
| Operating lease liabilities | 562 | 544 |
| Total current liabilities | 6,456 | 7,017 |
| Operating lease liabilities, non-current | 309 | 457 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is SELLAS Life Sciences Group, Inc.'s accounts payable?
- SELLAS Life Sciences Group, Inc. (SLS) reported accounts payable of $3.63M in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s accounts payable changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s accounts payable decreased by 3.3% year-over-year, from $3.76M to $3.63M.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s accounts payable has grown at a -8.7% compound annual growth rate (CAGR), from $4.66M to $2.95M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about SELLAS Life Sciences Group, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude